Twist Bioscience Corporation: Leerink Partners raises target price to $190 from $160
TWST•Leerink Partners raised its target price for Twist Bioscience Corporation to $190 from $160.
Related News
Oruka Therapeutics director Kristine M. Ball sells shares worth $1.89 million
ORKA•
Colombian regulator closes competition probe into Ecopetrol and subsidiaries
EC•
Microsoft says no indication FAA ground stop is related to its services
MSFT•
Cosan swings to 3Q26 net profit of BRL 190 million from 3Q25 loss
CSAN•
Nvidia fallout throws spotlight on Southeast Asia's AI boom
NVDA•